• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
News and impact
NIHR Biomedical Research Centre Leicester

NIHR Biomedical Research Centre Leicester

  • Home
  • About Us
    • Leadership Team
    • Our Impact
    • Our NIHR infrastructure
    • Governance
    • Inclusion
    • Strategies
    • Contact us
  • Our Research
    • Our Impact
    • Spotlight on our researchers
    • Cardiovascular
    • Data Innovation for Multiple Long-Term Health Conditions and Ethnic Health
    • Environment
    • Lifestyle
    • Personalised Cancer Prevention and Treatment
    • Respiratory and Infection
  • Patients and Public
    • Get Involved
    • Upcoming Public Involvement opportunities
    • Our approach to Public Involvement
    • Join the BioResource and Be Part of Research
    • Taking part in Clinical Trials
  • Industry and Partners
    • What we offer to industry
    • Collaborate with the Leicester BRC
    • Our partnerships
      • The NIHR Diet and Activity Research Translation (DART) Collaboration
  • For Researchers
    • Training
    • The Internal Resource Hub
    • Acknowledging and communicating your research
    • Guidance on Public Involvement (PPIE) for researchers
    • Advancing inclusion: transforming research culture in Leicester and beyond
    • PPI for Statistical Methodology and Research Techniques
  • News and Impact

Leicester experts uncover secrets of healthy ageing from the world’s oldest person

Sep 29, 2025

Scientists have studied the genetics and lifestyle factors that enabled María Branyas, officially the oldest person in the world until she died last year, to reach 117 years old.

the Van Geest facility

Researchers funded by the NIHR Leicester BRC at the University of Leicester’s van Geest Multi-Omics Facility carried out an analysis of thousands of proteins circulating in the blood of this exceptionally long-lived individual.  

By comparing her protein profile with those of other women across different age groups, the Leicester researchers could see what was unique about her biology.

Between 17 January 2023 and 19 August 2024, María Branyas, of Spain, was officially the world’s oldest person, until she died aged 117 years and 168 days. To uncover the secrets of her extraordinary longevity, a team of researchers has done a deep dive into her proteomics, epigenetics, microbiome and lifestyle.

María Branyas Morera
María Branyas Morera

Their findings have been published in Cell Reports Medicine and have been covered widely in international media.

When Maria was 116 years old, the team collected samples of her blood, saliva and stool, to analyse her genetics. “She had an exceptional genome enriched in variants in genes that are associated with enhanced lifespan in other species, such as dogs, worms and flies,” says team leader, Manel Esteller at the Josep Carreras Leukaemia Research Institute in Barcelona, Spain.

Maria, who showed no sign of dementia, also had many gene variants that keep blood lipid levels low, protecting the heart and cognition, says Esteller. “At the same time, she was devoid of gene variants associated with the risk of pathologies such as cancer, Alzheimer’s and metabolic disorders.”

María Branyas Morera
María Branyas Morera

Blood test results also revealed that her lipid metabolism was among the most efficient ever reported, according to the researchers. “Her lipid profile was amazing, with very low cholesterol,” says Esteller. “This was related to her frugal diet and genes that quickly metabolised damaging molecules.”

Esteller says Morera didn’t drink alcohol or smoke, and adhered to a Mediterranean diet, made up of lots of vegetables, fruits, legumes and olive oil. She also ate three servings of plain, sugar-free yoghurt every day.

The team’s tests also suggest that Morera retained an efficient immune system into old age and a gut microbiome characteristic of a much younger individual.

The collaboration with Leicester began when Professor Esteller approached Prof Salvador Macip, from Leicester’s Division of Molecular and Cell Biology, to contribute to the multiomics study. Julia Bonet, a PhD student from Professor Macip’s group, spent six months training and working in the mass spectrometry laboratory at the University of Leicester’s  van Geest Multi-Omics Facility.

Afterwards, Leicester’s Dr Thong Cao was contacted to work on the rare plasma samples from a 116-year-old woman (one of the oldest people ever documented).

Dr Cao said: “Because of our established expertise, we were asked to carry out the proteomics analysis. I then met with the first author, Dr Eloy Santos, to plan the work, and the samples were sent to us for detailed analysis using mass spectrometry at the Leicester van Geest Multi-Omics Facility.

“Our role was to use advanced mass spectrometry to study thousands of proteins circulating in the blood of this exceptionally long-lived individual. Proteins are the molecular ‘workhorses’ of the body and provide important clues about health and disease. By comparing her protein profile with those of other women across different age groups, we could see what was unique about her biology.

The Leicester analyses helped uncover:

  • That Maria’s blood proteins suggested a very low level of inflammation, which is unusual at such an advanced age and is often linked to healthier ageing
  • Signs of strong lipid and cholesterol transport systems: essentially, her body was very efficient at handling fats, which may have protected her cardiovascular health
  • The data also revealed enhanced detoxification and antioxidant responses that suggest her body had powerful mechanisms to counteract cellular stress
  • Altogether, these patterns pointed towards biological pathways that could help explain Maria remained healthy into extreme old age

D Cao added: “It was a privilege for Leicester to be part of this unique international study. Using our state-of-the-art proteomics facility, we were able to uncover biological signatures in the blood of one of the world’s oldest women that pointed to unusually low inflammation and strong protective mechanisms. These findings highlight how Leicester’s expertise in mass spectrometry can contribute to understanding the biology of healthy ageing.”

Professor Macip added: “This is a unique and groundbreaking study that highlights the biological complexity of ageing and provides clues to explain why some people have much healthy ageing that others. It is a much needed starting point of further studies that should help us translate the unique physiology of supercentenarians into strategies that can be applied to the general population”.

Further findings

Researchers also discovered high levels of Actinobacteriota bacteria in Branya’s gut, including the well-known probiotic Bifidobacterium. This typically declines with age, but is elevated in centenarians and supercentenarians, and it is thought to have multiple anti-ageing benefits, such as reducing inflammation.

Finally, the scientists tried to gauge whether Branya’s biological age differed substantially from her chronological age. This was done by creating an epigenetic clock based on her DNA methylation – the process in which DNA adds or removes chemical tags that help switch various genes on and off.

“Her biological age was an average 23 years younger than her chronological age, one of the reasons that she was alive,” says Esteller.

Previous research suggests that supercentenarians can have genetic variants associated with various medical conditions, such as Alzheimer’s disease or heart problems, but somehow have the means to endure them, leading to a long life. “Very few studies are available for supercentenarians. In these [previous ones], only one dimension is studied, e.g. [the] microbiome,” says Esteller. “Our study shows that overcoming such diseases is a combination of good genes plus the other factors: [a] beneficial microbiome, slowed-down biological age shown by a younger epigenome and an efficient immune system, plus the behaviour part – no smoking, no alcohol, low-fat diet, etc.”

Richard Faragher at the University of Brighton in the UK says the study demonstrates how many tests are now available to longevity researchers, but cautions that this is a case report of one individual and there is a “danger that a slightly unusual variant in, for example, a gene can be turned into a scientific ‘just-so story’ about its relevance to ageing”.

Instead, he says there are two main explanations for the survival of very long-lived individuals. “Firstly, that there is something special about them, for example genetically, and secondly, survivorship bias, aka they got lucky,” says Faragher.

To offer proof against her longevity just being luck, there would need to be evidence that Branya is part of a family in which people are known to be long lived, which isn’t presented in this study, he says.

Journal reference: Cell Reports Medicine DOI: 10.1016/j.xcrm.2025.102368

You can read the full paper in the Journal cell.com/cell-reports-medicine/fulltext/S2666-3791(25)00441-0

Category: Press ReleasesTag: cancer, data, Press Release, proteomics

Sidebar

Recent News

People with long Covid have drastically different microbiome in their lungs and mouth

New plan to tackle unreliable research antibodies could save millions and improve medical research

Study shows low energy diet combined with structured exercise reverses early onset type 2 diabetes in half of participants

Read more news stories

The NIHR Leicester BRC is part of the NIHR and hosted by the University Hospitals of Leicester NHS Trust in partnership with the University of Leicester,  Loughborough University and the University Hospitals of the Northamptonshire NHS Group.

Get in touch

NIHR Leicester Biomedical Research Centre

University Hospitals of Leicester NHS Trust
Research & Innovation
Leicester General Hospital
Gwendolen Road
Leicester, LE5 4PW

Contact us

Our Research

Spotlight on our researchers

Cardiovascular

Data Innovation for Multiple Long-Term Health Conditions and Ethnic Health

Environment

Personalised Cancer Prevention and Treatment

Lifestyle

Respiratory and Infection

About BRC

Our NIHR infrastructure

BRC clinical research during COVID-19

Our 2022 – 2028 strategy documents

Governance

Useful links

Our partnerships

Inclusion

Privacy notice

Cookie Policy

Copyright © NIHR Biomedical Research Centre: Leicester

  • LinkedIn
  • X
  • Facebook
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}